Posted on 4/23/20
Imara Appoints Edward R. Conner To Board
BOSTON, April 23, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 4/23/20
Brad Rowland Joins Login VSI’s Board of Advisors
BOSTON & AMSTERDAM--(BUSINESS WIRE)--Login VSI, the company dedicated to maximizing the end-user experience, today announced the appointment of Brad Rowland to the company’s board of advisors. . . .
Posted on 4/22/20
Mark Hirschhorn Joins the Board of Tapestry Telehealth
Tapestry Telehealth has added Mark Hirschhorn to its Board of Directors. As the CFO and COO of Teladoc Health from 2012 to 2019
Posted on 4/22/20
Edna Conway Joins the ProcessUnity Board of Directors
ProcessUnity, a leading provider of cloud-based applications for risk and compliance management, today announced that industry veteran Edna Conway
Posted on 4/21/20
Tony Zook Joins the Board of ViralClear Pharmaceuticals
BioSig Technologies, Inc. (NASDAQ: BSGM) today appointed Mr. Anthony Zook to the Board of Directors of its majority-owned subsidiary ViralClear Pharmaceuticals, Inc.
Posted on 4/21/20
X-Biotix Therapeutics Appoints Michael W. Bonney to Board
WALTHAM, Mass.--(BUSINESS WIRE)--X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of multiple novel antibiotic first in class compounds targeting multidrug-resistant (MDR) . . .
Posted on 4/19/20
Maguire Associates Appoints John Bonanno As CEO
Marking a strategic and timely transformation, Maguire Associates announces the appointment of John J. Bonanno
Posted on 4/17/20
Michael Coyle Joins Haemonetics Board of Directors
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology
Posted on 4/17/20
uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of Director
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs,
Posted on 4/16/20
Martin Lauber to Join ePropelled's Commercial Advisory Board
ePropelled, a leader in magnetic engineering technology for electro-magnetic motors, today announced the appointment of Martin Lauber to the company's Commercial Advisory Board.
Posted on 4/16/20
Meridian Associates Names Doug Reed CEO
Meridian Associates, a multi-disciplinary civil engineering, LiDAR mapping and survey firm, announced today that it
Posted on 4/16/20
Aternity Adds Alpna J. Doshi to Board of Directors
Aternity, the enterprise-class Digital Experience Management Company, today announced the appointment of Alpna J. Doshi to its Board of Directors.
Posted on 4/16/20
Spero Appoints Scott Jackson to its Board of Directors
Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments
Posted on 4/16/20
BrightSphere Names Suren Rana as Chief Executive Officer
BrightSphere Investment Group Inc. (NYSE: BSIG) announced today that it has appointed its Chief Financial Officer, Suren Rana, as its Chief Executive Officer and President effective . . .
Posted on 4/16/20
Solid Biosciences Appoints Ian F. Smith To Board
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy,
Posted on 4/15/20
BJ’s Wholesale Club Holdings Announces Change to Board of Directors
WESTBOROUGH, Mass.--(BUSINESS WIRE)--BJ’s Wholesale Club, Inc. (NYSE: BJ), a leading operator of membership warehouse clubs in the Eastern United States, announced today that Jonathan A. Seiffer . . .
Posted on 4/15/20
Mersana Therapeutics Appoints Martin Huber to Board
Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and
Posted on 4/15/20
Cardurion Pharmaceuticals Appoints Peter Lawrence CEO
Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment
Posted on 4/15/20
TCR² Therapeutics Appoints Dr. Axel Hoos Joins Its Board of Directors
TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer,
Posted on 4/14/20
Trinity Life Sciences Names Peter Hoenigsberg to Its Board
Trinity Life Sciences, a global leader in life sciences solutions, today announced it has named Peter Hoenigsberg to its Board of Directors.
Posted on 4/14/20
Dacarba Appoints Paul Roscoe CEO
Professional services firm Dacarba LLC, an Opportune LLP company, is pleased to announce that Paul Roscoe has joined the firm as Chief Executive Officer (CEO) to . . .
Posted on 4/9/20
KVH Industries Appoints Robert Tavares to Board of Directors
KVH Industries, Inc., (Nasdaq: KVHI), today announced that it has reached an agreement with Vintage Capital Management, LLC to appoint Robert Tavares
Posted on 4/8/20
OSSIO Appoints Gary Pruden to Board
OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors.
Posted on 4/8/20
aptihealth Names Dan Pickett CEO
aptihealth, the nation's leading innovator in tech-enabled behavioral health engagement, today announced the expansion
Posted on 4/7/20
Jean George Retires from Acceleron's Board
Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics
Boston
